المؤلفون: Jing Wang, Sheryl Coppola, Kristian M. Bowles, Al-Ola Abdallah, Emma Arriola, Orlando F. Bueno, Maria-Victoria Mateos, Gudrun Mander, Lura Morris, Jeremy A. Ross, Cristina Gasparetto

المساهمون: AbbVie Pharmaceuticals

المصدر: Digital.CSIC. Repositorio Institucional del CSIC
instname

مصطلحات موضوعية: Male, Oncology, Cancer Research, medicine.medical_specialty, BCL2, Immunomodulatory agent, Phases of clinical research, Neutropenia, Dexamethasone, Targeted therapy, Venetoclax, chemistry.chemical_compound, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Adverse effect, Multiple myeloma, Aged, Lenalidomide, Sulfonamides, business.industry, Hematology, Bridged Bicyclo Compounds, Heterocyclic, Pomalidomide, medicine.disease, Plasma cell dyscrasia, Progression-Free Survival, Thalidomide, Tolerability, chemistry, Female, Multiple Myeloma, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c70ff222b62d396ee5c5c4116539a632
http://hdl.handle.net/10261/261010

المؤلفون: Tu Xu, Jaclyn Cordero, Wijith Munasinghe, Lura Morris, Maria Verdugo, Orlando F. Bueno, Sarah R. Mudd, Kevin J. Freise, Jeremy A. Ross, Joel D. Leverson

المصدر: Journal of Clinical Oncology. 35:TPS8056-TPS8056

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Venetoclax, medicine.disease, Carfilzomib, chemistry.chemical_compound, chemistry, Refractory, Open label study, Internal medicine, Relapsed refractory, Medicine, In patient, business, Multiple myeloma, Dexamethasone, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::42d0f4f70758692f649ead29999ea6aa
https://doi.org/10.1200/jco.2017.35.15_suppl.tps8056

المؤلفون: Joseph R. Mikhael, Suresh Agarwal, Lura Morris, Brigitte Pegourie, Lotfi Benboubker, Jeremy A. Ross, Ming Zhu, Cyrille Touzeau, Jonathan L. Kaufman, Ravi Vij, Martin Dunbar, Paulo Maciag, Thierry Facon, Stefanie Alzate, Sari H. Enschede, Joel D. Leverson, Philippe Moreau, Rod A. Humerickhouse, Shaji Kumar, Martine Amiot

المصدر: Blood. 126:4219-4219

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Anemia, Venetoclax, Nausea, Immunology, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Surgery, Tumor lysis syndrome, chemistry.chemical_compound, chemistry, Internal medicine, Cohort, Medicine, medicine.symptom, business, Adverse effect, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::55dc9d5de791cb0cfbebf90174a10627
https://doi.org/10.1182/blood.v126.23.4219.4219

المؤلفون: Cyrille Touzeau, Wijith Munasinghe, Maria Verdugo, Andrew W. Roberts, Simon J. Harrison, Rod A. Humerickhouse, Ahmed Salem, Asher Chanan-Khan, Paulo Maciag, Amit Agarwal, Sari H. Enschede, Ming Zhu, David E. Darden, Thierry Facon, Shaji Kumar, Joel D. Leverson, Lura Morris, Jeremy A. Ross, Philippe Moreau

المصدر: Blood. 126:3038-3038

مصطلحات موضوعية: medicine.medical_specialty, Venetoclax, Bortezomib, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Off-label use, Biochemistry, Transplantation, chemistry.chemical_compound, chemistry, Internal medicine, Relapsed refractory, medicine, business, Multiple myeloma, Dexamethasone, Lenalidomide, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::abc67dacb2e4d3f096e98edf278f193e
https://doi.org/10.1182/blood.v126.23.3038.3038

المؤلفون: David E. Darden, Lura Morris, Ahmed Salem, Jeremy A. Ross, Simon J. Harrison, Daniel Lebovic, Joel D. Leverson, Ming Zhu, Wijith Munasinghe, Philippe Moreau, Sari H. Enschede, Andrew W. Roberts, Asher Chanan-Khan, Cyrille Touzeau, Thierry Facon, Rod A. Humerickhouse, Amit Agarwal

المصدر: Journal of Clinical Oncology. 33:8580-8580

مصطلحات موضوعية: medicine.medical_specialty, Cancer Research, Anemia, Peripheral edema, Gastroenterology, chemistry.chemical_compound, Refractory, immune system diseases, Internal medicine, hemic and lymphatic diseases, Medicine, Decompensation, neoplasms, Multiple myeloma, Dexamethasone, Cell survival, Lenalidomide, business.industry, Venetoclax, Bortezomib, Antagonist, Hematology, medicine.disease, Oncology, chemistry, Relapsed refractory, Cancer research, medicine.symptom, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0963bd75bb6b930132dac0a93e9eef5
https://doi.org/10.1200/jco.2015.33.15_suppl.8580

المؤلفون: Sari H. Enschede, Joel D. Leverson, Shaji Kumar, Ming Zhu, Rod A. Humerickhouse, Philippe Moreau, Joseph R. Mikhael, Jonathan L. Kaufman, Lura Morris, Ravi Vij, Martin Dunbar, Jeremy A. Ross, Stefanie Alzate, Cyrille Touzeau, Thierry Facon, Suresh Agarwal, Martine Amiot

المصدر: Journal of Clinical Oncology. 33:8576-8576

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cancer Research, business.industry, Venetoclax, Hematology, Pharmacology, medicine.disease, chemistry.chemical_compound, chemistry, Internal medicine, Relapsed refractory, Medicine, business, Multiple myeloma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdcdb7fbeeb41d30ace900f78567f63
https://doi.org/10.1200/jco.2015.33.15_suppl.8576